Waiting
Processando Login

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / TMEM200A: A Novel Oncogene Regulating EMT and… / Determining the Cell Viability of TMEM200A siRNA…
JoVE Journal
Cancer Research

É necessário ter uma assinatura JoVE para assistir este Faça login ou comece sua avaliação gratuita.

JoVE Journal Cancer Research
Determining the Cell Viability of TMEM200A siRNA Transfected HGC-27 Cell Lines Using CCK-8 Assays (Video) | JoVE
 
Click here for the English version

Determining the Cell Viability of TMEM200A siRNA Transfected HGC-27 Cell Lines Using CCK-8 Assays (Video) | JoVE

TMEM200A: A Novel Oncogene Regulating EMT and PI3K/AKT in Gastric Cancer

Article DOI: 10.3791/200745-v • 00:57 min • September 15th, 2023
September 15th, 2023 •
1, 1, 2, 1, 1, 1
1Department of Histology and Embryology, Youjiang Medical University for Nationalities, 2Department of Pathophysiology, Youjiang Medical University for Nationalities

Tags

TMEM200A Multiomics analyse pan-cancer biomarkør transmembranprotein immuninfiltrasjon RNA-seq data diagnostisk biomarkør prognostisk biomarkør gastrisk kreft (GC) in vitro cellekulturer knockdown kvantitativ sanntids polymerasekjedereaksjon (qPCR) vestlig blotting ondartet oppførsel tumordannelse epitel-mesenkymal overgang (EMT) PI3K / AKT signalvei proliferasjonshemming
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter